Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas. - Wikidata - awgldk - TriplyDB

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.

http://www.wikidata.org/entity/Q43115465

about

Stem cells as cellular vehicles for gene therapy against glioblastoma Gene therapy for brain tumors: basic developments and clinical implementation Cellular immunotherapy for pediatric solid tumors Antigen-specific immune responses and clinical outcome after vaccination with glioma-associated antigen peptides and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in children with newly diagnosed malignant brainstem Phase II trial of tipifarnib and radiation in children with newly diagnosed diffuse intrinsic pontine gliomas.Childhood brain tumors: epidemiology, current management and future directions.Pediatric low-grade gliomas.Mesenchymal transition and PDGFRA amplification/mutation are key distinct oncogenic events in pediatric diffuse intrinsic pontine gliomas.Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma.Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeutics.Engineering toxin-resistant therapeutic stem cells to treat brain tumors Increased expression of tumor-associated antigens in pediatric and adult ependymomas: implication for vaccine therapy YM-155 potentiates the effect of ABT-737 in malignant human glioma cells via survivin and Mcl-1 downregulation in an EGFR-dependent context.Biologically targeted therapeutics in pediatric brain tumors.Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway Ependymomas: development of immunotherapeutic strategies.Genomic Insights into Diffuse Intrinsic Pontine Glioma.Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.Cellular immunotherapy for high-grade glioma.Highlights of the second international conference on "Immunotherapy in Pediatric Oncology".Expression of cancer-testis genes in brain tumors: implications for cancer immunotherapy.IL-13 receptor-directed cancer vaccines and immunotherapy.Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?Vaccination strategies for neuro-oncology.Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive Glioma.Convection-Enhanced Delivery for Diffuse Intrinsic Pontine Glioma Treatment.Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas.Advances and challenges: dendritic cell vaccination strategies for glioblastoma.Survivin and gliomas: A literature review Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma.Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomas.Trivalent CAR T-cells Overcome Interpatient Antigenic Variability in Glioblastoma.Gliomas in children.Antigen-specific immunoreactivity and clinical outcome following vaccination with glioma-associated antigen peptides in children with recurrent high-grade gliomas: results of a pilot study.Signaling pathways and mesenchymal transition in pediatric high-grade glioma.Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.Gene therapy and targeted toxins for glioma

P2860

Q26771835-6A055EE5-3894-48AC-A9E2-3262A8791CA2 Q26829086-D5ADDE14-A1AC-48B2-BBF0-142874D2F4B7 Q27014912-37D6CC80-CB3B-406F-8BBB-1046CAC3DC5F Q33796170-8F4922D8-7BB6-490E-B106-248AF8069D9B Q33825938-F7E4C6C2-3D2A-466E-AD1B-C659482D786E Q33970971-7A22CD62-19BF-4465-A27B-4883601FEB23 Q34051368-742AA857-9B1A-4535-B08B-90AADD867635 Q34184430-172C21DC-B78A-4633-BE6D-C4D1FD2AF607 Q34339843-ECF638DF-611A-4430-8FC8-627D9D32C8DA Q34359268-AB0113FC-ECE8-44C2-AAF4-E21A19A836E9 Q34444939-8E2008D7-F172-4DDD-9405-1CDFE8D80DEE Q36536409-73C0FD00-6E0E-484C-B1BF-C8478B55FAB4 Q36681060-7836CBCF-D43A-4057-B314-32EC9E69D927 Q36844744-5C803F54-E7E0-458D-B09E-05CA20A43FEE Q37027010-6A357106-B2E7-4726-A234-65B32FFEE45D Q37678294-3D95E661-17B3-49BD-8F35-48C464EE72BB Q37723508-B02E0929-A855-4758-B0D7-5D1063228DCC Q37804933-B2D7D7D2-E26E-4CF9-87F2-E43DFB510DBD Q37851972-3D80EBD4-8620-41E7-AF4A-A75E9F749355 Q37919880-AC23BCCB-69C8-454C-8AC1-A31AC3744F25 Q37965751-63999615-4C0F-4355-BA98-011793F840A5 Q38003478-29E3F873-3B5E-4E58-8554-2A084409D60F Q38233425-ED72F75E-F589-4B4E-BDB0-15A6B920C9D8 Q38620079-4107F34C-6972-4E8A-8D5A-8B3023864FA4 Q38823847-48E657B3-9B12-4655-ADEA-B22E771BFCCD Q38852756-A927CE1D-5F30-414A-BCB2-CE93FB0805AD Q38869957-E122A857-2CC9-40C9-856C-2BF3A6D31641 Q38921652-AD6D5C47-25D4-468E-A8F3-774990B44F9E Q38944673-7B15A098-DD75-4D7E-9DCE-499100FDB116 Q39111239-F61AC0FB-1145-47D2-BE44-BB033824510A Q42431588-9A9AD126-9BD3-457E-8F3D-4D196E5EC81B Q42696122-D667B8AC-9E1C-4400-833D-012BAFF0E421 Q45343976-13101D4B-072E-4145-905B-DCDE36632084 Q45933704-D14ECF68-52E9-42E1-83A9-521B2042FAF2 Q48258004-0536D6E7-DBEB-4956-B00B-BDDF086F7DA7 Q48564522-2EF1580A-0F5B-48E1-A20E-C1C0111BB157 Q57006162-F2982831-DF93-4771-BD49-70900DECC49A

P2860

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.

http://www.wikidata.org/entity/Q43115465

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Expression of glioma-associate ...... em and non-brain stem gliomas.

@en

Expression of glioma-associate ...... em and non-brain stem gliomas.

@nl

type

label

Expression of glioma-associate ...... em and non-brain stem gliomas.

@en

Expression of glioma-associate ...... em and non-brain stem gliomas.

@nl

prefLabel

Expression of glioma-associate ...... em and non-brain stem gliomas.

@en

Expression of glioma-associate ...... em and non-brain stem gliomas.

@nl

P1433

Q43115465-8F3B2C18-B169-4094-A32A-FFCFA4EB1428

P1476

Q43115465-EDED12C5-A89B-46D8-B726-F741D949D71E

P2093

Q43115465-31DDDD3F-884A-47CE-987F-834D8EBFD00D

Q43115465-9019E118-C349-4B86-A211-290612599BBF

Q43115465-9A903B0B-4BAE-4649-B4FD-3DDB250E5C8A

Q43115465-9EF5FC89-9696-4B2E-9B88-296B7732D76A

Q43115465-D9005ADF-D505-43A6-B907-38F778EA8289

P2860

Q43115465-082A22A1-BC97-4C46-AF28-88B81BF06ADE

Q43115465-1BB0CBD9-9098-4E25-AAEB-58891A6EF9C7

Q43115465-1FA42083-EC69-499C-85A0-E9F7123CB58E

Q43115465-205BFABD-59E4-44AF-A511-1BC47EB320F6

Q43115465-231F83B6-A2EC-4367-B20C-DC18A4886920

Q43115465-28355521-99CD-4487-81E6-EFDDCA8871EB

Q43115465-32648AB9-3A39-4365-A2BF-D951ECAF6AF0

Q43115465-3E51ECE3-47AA-430E-9FC6-B14BDA8488E4

Q43115465-46E6EACD-FB24-4EA1-A02D-151E8E0DE871

Q43115465-477FE6F2-1ECE-4BA7-B4C1-0E85555CC500

P2888

Q43115465-47D1ABB6-6715-4F86-929D-FFD300D2E032

P304

Q43115465-26697186-C221-4750-A4D7-F4B81B6D9404

P31

Q43115465-9FE58F03-2AA0-40DB-93F4-0CB74C9AC5B5

P356

Q43115465-C2DF0FE3-16B6-4938-9CB6-A438F49FB85C

P433

Q43115465-5CDD47F4-4223-432F-802D-89231E4A04A1

P478

Q43115465-5B533E5D-FBC0-47CE-92D3-90F4A2B5BA2F

P50

Q43115465-F359F735-91F6-4B56-986C-AE315F6CC9FF

P577

Q43115465-17829FE1-A327-42FB-B498-8A769FFA51CC

P5875

Q43115465-11AAF44A-153D-4837-9669-C0086648AF97

P6179

Q43115465-A6EA756A-A624-48BA-B0C1-25BECE952F73

P698

Q43115465-6F69DD16-A8FC-4152-B626-23DDFCEC9431

P932

Q43115465-3ACDFB07-9217-4416-9965-F1A2023C5C7C

P356

S11060-008-9566-9

P1433

Journal of Neuro-Oncology

P1476

Expression of glioma-associate ...... tem and non-brain stem gliomas

@en

P2093

Heather A McDonald

http://www.w3.org/2001/XMLSchema#string

Hideho Okada

http://www.w3.org/2001/XMLSchema#string

Ian F Pollack

http://www.w3.org/2001/XMLSchema#string

Keri L Low

http://www.w3.org/2001/XMLSchema#string

Ronald L Hamilton

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation

Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors

Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain

IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis

Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo

Diffuse brain stem glioma. A review of stereotactic biopsies.

Eph receptors and ephrin ligands: embryogenesis to tumorigenesis.

Identification of interleukin-13 receptor alpha2 peptide analogues capable of inducing improved antiglioma CTL responses.

EphA2 as a novel molecular marker and target in glioblastoma multiforme.

EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.

P2888

s11060-008-9566-9

P304

245-250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-008-9566-9

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5528699

http://www.w3.org/2001/XMLSchema#string

P6179

1014842319

http://www.w3.org/2001/XMLSchema#string

P698

18324354

http://www.w3.org/2001/XMLSchema#string

P932

2561297

http://www.w3.org/2001/XMLSchema#string